Boxer Capital, LLC - 11 Aug 2023 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
Other*
Signature
/s/ Aaron I. Davis, Chief Executive Officer, Boxer Capital, LLC
Issuer symbol
N/A
Transactions as of
11 Aug 2023
Net transactions value
+$34,999,449
Form type
4
Filing time
15 Aug 2023, 21:38:44 UTC
Previous filing
24 May 2023
Next filing
25 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Purchase $1,599,417 +57,533 +25% $27.80 287,866 11 Aug 2023 See Footnote F1
transaction MRTX Common Stock Purchase $33,400,032 +1,201,440 +60% $27.80 3,201,440 11 Aug 2023 Direct F2
holding MRTX Common Stock 47,517 11 Aug 2023 See Footnote F3
holding MRTX Common Stock 3,135,966 11 Aug 2023 See Footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are owned directly by MVA Investors, LLC ("MVA Investors"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
F2 These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). Boxer Asset Management Inc. ("Boxer Management") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Each of Messrs. Fuglesang, Dissanayake and Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
F3 These securities are owned directly by Mr. Davis. Each reporting person other than Mr. Davis disclaims beneficial ownership of these securities.
F4 These securities are owned directly by Braslyn Ltd. Mr. Lewis is the sole indirect owner of Braslyn Ltd. Each reporting person other than Mr. Lewis disclaims beneficial ownership of these securities.

Remarks:

The reporting persons may be deemed members of a group that beneficially owns more than 10% of the outstanding shares of common stock, $0.001 par value per share, of Mirati Therapeutics, Inc.